Davenport & Co LLC
- SEC CIK
- 0000887777
- Latest filing
- Jul 13, 2026
TSHA holding history
Taysha Gene Therapies, Inc. in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TSHA overviewAll 13F holders of TSHAFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −27,170−100.0% | Sold out | Holders |
| Q2 2022 | 27,170 | $101.0K | <0.1% | −500−1.8% | Reduced | Holders |
| Q1 2022 | 27,670 | $180.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 27,670 | $322.0K | <0.1% | −55,100−66.6% | Reduced | Holders |
| Q3 2021 | 82,770 | $1.54M | <0.1% | +69,020+502.0% | Added | Holders |
| Q2 2021 | 13,750 | $292.0K | <0.1% | −6,400−31.8% | Reduced | Holders |
| Q1 2021 | 20,150 | $409.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.